Katrin Almstedt

Mainz, RP 55131, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical Relevance.

Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical Relevance.

Journal: Oncology research

Published: August 22, 2025

Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.

Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.

Journal: International journal of cancer

Published: September 20, 2024

Prognostic Impact of Acute and Chronic Inflammatory Interleukin Signatures in the Tumor Microenvironment of Early Breast Cancer.

Prognostic Impact of Acute and Chronic Inflammatory Interleukin Signatures in the Tumor Microenvironment of Early Breast Cancer.

Journal: International journal of molecular sciences

Published: July 18, 2024

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity.

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity.

Journal: Oncotarget

Published: June 20, 2024

BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer.

BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer.

Journal: Biomedicines

Published: May 31, 2024

Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.

Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 08, 2024

Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.

Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.

Journal: Geburtshilfe und Frauenheilkunde

Published: May 01, 2024

Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers.

Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers.

Journal: Cancers

Published: March 01, 2024

Changes in modifiable risk factors in women at increased risk for breast and ovarian cancer during the COVID-19 pandemic.

Changes in modifiable risk factors in women at increased risk for breast and ovarian cancer during the COVID-19 pandemic.

Journal: Heliyon

Published: December 10, 2023

Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis.

Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis.

Journal: Frontiers in oncology

Published: December 09, 2023

Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.

Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.

Journal: Geburtshilfe und Frauenheilkunde

Published: November 17, 2023

Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer.

Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer.

Journal: International journal of molecular sciences

Published: September 20, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026